Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast cancer progressing after anthracycline and taxane

被引：0
|
作者：
Ozdemir, Nuriye Yildirim [1 ]
Abali, Huseyin [1 ]
Oksuzoglu, Berna [1 ]
Budakoglu, Burcin [1 ]
Uncu, Dogan [1 ]
Guler, Tunc [1 ]
Zengin, Nurullah [1 ]
Hastanesi, Ankara Numune [1 ]
机构：
[1] Ankara Numune Hastanesi Med Onkol Klin, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes
    Oeksuezoglu, Berna
    Abali, Huseyin
    Hayran, Mutlu
    Yildirim, Nuriye
    Budakoglu, Burcin
    Zengin, Nurullah
    CHEMOTHERAPY, 2008, 54 (05) : 352 - 356
  • [2] Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
    Thomas, Eva S.
    Gomez, Henry L.
    Li, Rubi K.
    Chung, Hyun-Cheol
    Fein, Luis E.
    Chan, Valorie F.
    Jassem, Jacek
    Pivot, Xavier B.
    Klimovsky, Judith V.
    de Mendoza, Fernando Hurtado
    Xu, Binghe
    Campone, Mario
    Lerzo, Guillermo L.
    Peck, Ronald A.
    Mukhopadhyay, Pralay
    Vahdat, Linda T.
    Roche, Henri H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5210 - 5217
  • [3] Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
    Thomas, Eva S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2223 - 2223
  • [4] Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
    Wang, Jiayu
    Fan, Ying
    Xu, Binghe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 597 - 603
  • [5] Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
    Jiayu Wang
    Ying Fan
    Binghe Xu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 597 - 603
  • [6] Cost Effectiveness of Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
    Reed, Shelby D.
    Li, Yanhong
    Anstrom, Kevin J.
    Schulman, Kevin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2185 - 2191
  • [7] Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer
    El-Helw, L
    Coleman, RE
    BREAST, 2005, 14 (05): : 368 - 374
  • [8] Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients
    Ozdemir, N.
    Aksoy, S.
    Sendur, M. A. N.
    Akinci, M. B.
    Yazici, O.
    Budakoglu, B.
    Abali, H.
    Oksuzoglu, B.
    Zengin, N.
    JOURNAL OF BUON, 2013, 18 (04): : 831 - 837
  • [9] Combination chemotherapy with gencitabine and cisplatin in anthracycline and taxane pretreated metastatic breast cancer
    Peria, F. M.
    Zola, F. E.
    Tiezzi, D. G.
    Carrara, H. H.
    Philbert, P. M.
    Marana, H. R.
    Andrade, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Vinorelbine; An active and well tolerated treatment for anthracycline pre-treated metastatic breast cancer
    Mustafa, M
    Walsh, G
    Smith, IE
    Johnston, SRD
    BRITISH JOURNAL OF CANCER, 1999, 80 : 103 - 103
12345